Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 431708
Gene Symbol: MDD1
MDD1
0.010 Biomarker group BEFREE Davidson Trauma Scale ([DTS]; diagnostic proxy for ASD and PTSD; clinical cutoff=40, with higher score=higher severity) and the Patient Health Questionnaire-9 ([PHQ-9]; diagnostic proxy for MDD; clinical cutoff=10, with higher score=higher severity) at pretreatment, immediate posttreatment, and 1 month posttreatment. 30776324 2020
Entrez Id: 6326
Gene Symbol: SCN2A
SCN2A
0.010 GeneticVariation group BEFREE ASD-associated SCN2A mutations impair the encoded protein Na<sub>V</sub>1.2, a sodium channel important for action potential initiation and propagation in developing excitatory cortical neurons. 31230762 2019
Entrez Id: 4204
Gene Symbol: MECP2
MECP2
0.010 Biomarker group BEFREE ConvNetACh then successfully detected impairments in all ASD mouse models tested except in MeCP2-rescued mice. 31332003 2019
Entrez Id: 84173
Gene Symbol: ELMOD3
ELMOD3
0.010 Biomarker group BEFREE Homozygous 2p11.2 deletion supports the implication of ELMOD3 in hearing loss and reveals the potential association of CAPG with ASD/ID etiology. 30284680 2019
Entrez Id: 4488
Gene Symbol: MSX2
MSX2
0.010 Biomarker group BEFREE In this study, we used Msx2 conditional knockout (CKO) mice as a model and found that Msx2 deficiency in surface ectoderm induced ASD. 30683901 2019
Entrez Id: 94121
Gene Symbol: SYTL4
SYTL4
0.010 GeneticVariation group BEFREE We describe a 7-year-old male with high functioning autism spectrum disorder (ASD) and maternally-inherited rare missense variant of Synaptotagmin-like protein 4 (<i>SYTL4)</i> gene (Xq22.1; c.835C>T; p.Arg279Cys) and an unknown missense variant of Transmembrane protein 187 (<i>TMEM187</i>) gene (Xq28; c.708G>T; p. Gln236His). 31323913 2019
Entrez Id: 3552
Gene Symbol: IL1A
IL1A
0.010 Biomarker group BEFREE ASD samples were examined as a whole group and with respect to the previously defined IL-1ß/IL-10-based ASD subgroups (high, normal, and low groups). 31551826 2019
Entrez Id: 6647
Gene Symbol: SOD1
SOD1
0.010 Biomarker group BEFREE ▵T-SOD in plasma for all ASD-treated groups was smaller than the control and IV groups. 30367819 2019
Entrez Id: 51742
Gene Symbol: ARID4B
ARID4B
0.010 Biomarker group BEFREE ASD subjects were stratified into subpopulations based on shared metabolic phenotypes associated with BCAA dysregulation. 30446206 2019
Entrez Id: 3822
Gene Symbol: KLRC2
KLRC2
0.010 AlteredExpression group BEFREE Significant overexpression of NKG2C in hf-ASD patients (<i>p</i> = 0.0005), indicative of viral infections, was inversely correlated with the NKp46 receptor level (<i>r</i> = - 0.67; <i>p</i> < 0.0001), regardless of the IgG status of tested pathogens. 31123562 2019
Entrez Id: 7040
Gene Symbol: TGFB1
TGFB1
0.010 AlteredExpression group BEFREE Immunofluorescence microscopy images showed a two times stronger expression of fluorescence in the ASD-treated group than in that treated with TGF-β1. 31474744 2019
Entrez Id: 285
Gene Symbol: ANGPT2
ANGPT2
0.010 Biomarker group BEFREE Angiopoietin-2 (Ang-2) was higher in Fontan patients (8,875.4 ± 3,336.9 pg/mL) versus the ASD group (1,663.6 ± 587.3 pg/mL, p < 0.0001). 31797976 2019
Entrez Id: 1571
Gene Symbol: CYP2E1
CYP2E1
0.010 GeneticVariation group BEFREE ASD DMRs at CYP2E1 and IRS2 reached genome-wide significance, replicated by pyrosequencing and correlated with expression differences in brain. 31009952 2019
Entrez Id: 822
Gene Symbol: CAPG
CAPG
0.010 Biomarker group BEFREE Homozygous 2p11.2 deletion supports the implication of ELMOD3 in hearing loss and reveals the potential association of CAPG with ASD/ID etiology. 30284680 2019
Entrez Id: 2917
Gene Symbol: GRM7
GRM7
0.010 GeneticVariation group BEFREE An induced pluripotent stem cells line (SDQLCHi014-A) derived from urine cells of a patient with ASD and hyperactivity carrying a 303 kb de novo deletion at chr3p26.1 implicating GRM7 gene. 31707215 2019
Entrez Id: 4089
Gene Symbol: SMAD4
SMAD4
0.010 GeneticVariation group BEFREE Through this case report we aim to discuss the pathophysiology of juvenile polyposis syndrome (JPS), highlight what we believe to be a novel presentation of comorbid BMPR1A mutation and ASD and hypothesise that patients with BMPR1A mutation and JPS may be at risk of previously unrecognised cardiovascular complications analogous to the previous association of SMAD4 JPS and cardiac abnormalities. 31229977 2019
Entrez Id: 847
Gene Symbol: CAT
CAT
0.010 AlteredExpression group BEFREE ASD significantly increased the expression of anti-oxidant enzymes (GSH, SOD, and CAT) in both liver and vascular tissue, reduced blood lipid levels (TG, TC, and LDL-C), and decreased lipid deposition in the liver and atherosclerotic lesion size in ApoE<sup>-/-</sup> mice. 30999121 2019
Entrez Id: 8216
Gene Symbol: LZTR1
LZTR1
0.010 GeneticVariation group BEFREE All probands with LZTR1 variants had cardiac defects, including hypertrophic cardiomyopathy and atrial septal defect. 30368668 2019
Entrez Id: 64374
Gene Symbol: SIL1
SIL1
0.010 Biomarker group BEFREE Results revealed a pragmatic continuum with significantly better scores for HR-TD than HR-BAP or HR-ASD, and HR-BAP than HR-ASD. 30488153 2019
Entrez Id: 6792
Gene Symbol: CDKL5
CDKL5
0.010 Biomarker group BEFREE We found that both idiopathic (BTBR) and genetic (CDKL5- and MeCP2-deficient) mouse models of ASD display an early, impaired cholinergic neuromodulation as reflected in altered spontaneous pupil fluctuations. 31332003 2019
Entrez Id: 79937
Gene Symbol: CNTNAP3
CNTNAP3
0.010 Biomarker group BEFREE The critical role of ASD-related gene CNTNAP3 in regulating synaptic development and social behavior in mice. 31150793 2019
Entrez Id: 11331
Gene Symbol: PHB2
PHB2
0.010 Biomarker group BEFREE Results revealed a pragmatic continuum with significantly better scores for HR-TD than HR-BAP or HR-ASD, and HR-BAP than HR-ASD. 30488153 2019
Entrez Id: 55349
Gene Symbol: CHDH
CHDH
0.010 Biomarker group BEFREE We also found large increases in specific CHD subtypes during spring, including a 34.0% (95% CI, 4.9%-70.8%) increase in conotruncal CHD in the South and a 38.6% (95% CI , 9.9%-75.1%) increase in atrial septal defect in the Northeast. 30696385 2019
Entrez Id: 2332
Gene Symbol: FMR1
FMR1
0.010 Biomarker group BEFREE This study was designed to (1) describe ASD symptoms in adolescent and young adult males with FXS (n = 44) and (2) evaluate the contributions to ASD severity of cognitive, language, and psychiatric factors, as well as FMRP (the protein deficient in FXS). 30382442 2019
Entrez Id: 84650
Gene Symbol: EBPL
EBPL
0.010 Biomarker group BEFREE ERP evidence of semantic processing in children with ASD. 30974225 2019